DempoChem Logo
  1. HomeHome
  2. /ProductsProducts
  3. /Building BlocksBuilding Blocks
  4. /Organic Building BlocksOrganic Building Blocks
  5. /Alicyclic HydrocarbonsAlicyclic Hydrocarbons
  6. /Cholesteryl hemiazelateCholesteryl hemiazelate
Chemical structure of CAS 596592-83-5

Cholesteryl hemiazelate

CAS No.596592-83-5
MDL No.N/A
MFC36H60O4
MW556.90
InChI KeyLSKNQPNXBZAGBW-ZTOACVCWSA-N
CUSTOM SYNTHESIS

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
- -On RequestOn Request
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.596592-83-5
Product NameCholesteryl hemiazelate
Heavy Atom Count40Rotatable Bond Count14
Atom Stereo Count8Bond Stereo Count0
HBA3HBD1
TPSA63.600 ŲCharge0
Exact Mass556.44916Complexity891.23
pKa4.721XLogP9.755

Related Articles

Studies related to this compound and its mechanism of action

Cholesteryl hemiazelate identified in CVD patients causes in vitro and in vivo inflammation.

Journal of lipid research • Vol. 64, Issue 9 • 2023
PMID: 37482218PMC: PMC10450993DOI: 10.1016/j.jlr.2023.100419

Documentation

Similar Products

  • Cholesteryl hemisuccinate tris salt

    CAS No.102601-49-0

Your Partner for
Complex Chemistry
logo
  • About Us
  • Perspectives
  • Products
  • Contact
  • Preclinical Development
  • Technologies
  • Custom Synthesis
Ready to start your project?

Provide your target molecule or project specifications to align on a tailored development and scale-up pathway with our scientific team.

START A PROJECT
Westerstraat 10, 3016 DH, Rotterdam, The Netherlands
Westerstraat 10, 3016 DH, Rotterdam, The Netherlands
logo

All products are supplied strictly for research and development use only and are not intended for human or veterinary administration, diagnostic use, or therapeutic use. Preclinical and related services are provided solely for research and development purposes and do not constitute clinical diagnosis, treatment, or veterinary care.

©2026 DempoChem. All Rights Reserved.
DHLFedExUPSPostNL
CLIENT PORTAL|TERMS AND CONDITIONS|PRIVACY POLICY|
  • Products
    • CDMO Compounds
    • API & Candidates
  • Services
    CDMO & Manufacturing
    • Custom Synthesis
    • Process Development
    • Lab To Pilot
    • Commercialization
    • Generic APIs
    CRO
    • Preclinical
    • Pharmacology & Efficacy
    • DMPK & Bioanalysis
    • Toxicology & Safety
    • Disease Models
    Technologies
    • High-Potent
    • Chiral Synthesis
    • Cloud Synthesis
    • Fermentation
    • Flow Chemistry
    • Biocatalysis
    Support
    • Regulatory Support
    • Supply Chain Solutions
  • About
  • Perspectives
  • Contact